DA10--Micromedex (VA-26-00045954)

Amendment / Modification

This amendment updates the "Statement of Need - Micromedex" document. The specific changes are detailed in the attached "Updated - Statement of Need - Micromedex" document.

• Statement of Need (updated)

Potential bidders should refer to the attached updated "Statement of Need - Micromedex" for any changes to requirements or scope that may affect their proposals. No changes to submission deadlines or evaluation factors are indicated in this amendment notice.

Statement of Need (SON)

This Statement of Need outlines the requirement for the Cheyenne VA Medical Clinic to retain access to the Micromedex and Poison Index information platform. This access is crucial for effective clinical decision-making by providing reliable, evidence-based information.

The procurement covers access to the full suite of Micromedex resources, including:

• Detailed drug information
• Disease and condition management content
• Toxicology data
• Drug interaction checker
• IV compatibility information

Key objectives include:

• Providing healthcare professionals with comprehensive, evidence-based clinical information.
• Improving patient care quality through enhanced clinical decision support.
• Ensuring access to the latest drug information (dosing, contraindications, adverse effects).
• Enabling quick and accurate drug interaction checks and management of toxicology concerns.

Specific deliverables include:

• Access to the full Micromedex database.
• User licenses for healthcare professionals.
• Training and support materials.
• Integration capabilities with existing Electronic Health Records (EHR) systems (if applicable).
• Regular updates to ensure information currency.
• Access to customer support.

Delivery Information: Cheyenne VA Medical Center 2365 EAST PERSHING BLVD CHEYENNE, WY 82001

(Note: Specific contract period of performance is not detailed in this document.)

• Access to customer support and regular updates are required.
• Integration with existing EHR systems is a potential requirement.

Decision for Sole Source Award

This document details a sole source award decision for access to the Micromedex database for the Cheyenne VA. The award is made in accordance with RFO 12.102(a).

• Firm-fixed price purchase order for access to the Micromedex database.

• The database is integrated with the Computerized Patient Record System (CPRS) and is the standard pharmaceutical decision support and Toxicology Management system used by most VA Health Care Systems.

• Provides access to drug and medication information, including Medication Safety, Drug Interactions, Alternative Medicine and Therapies, IV compatibility, Formulary Solutions, Pediatric and Neonatal Evidence for Patient Safety, and Global Drug Information.

• Includes cloud service and IBM Watson technology for immediate access to evidence-based information.

• Period of Performance: Base year with four one-year option periods (totaling five years).

• Contract type: Firm-fixed price purchase order.

• Estimated value: [Redacted].

• Micromedex software and cloud services have been in use at the Cheyenne VA for nearly a decade.

• Pepid was consulted; integrating their system would be more costly than continuing with the current program. Pepid offers similar products but integration is not fiscally warranted. Cloud service is not available on Pepid.

• Lexicomp was consulted; they do not offer similar products to Micromedex and cannot support the IBM Watson Technology. Switching to Lexicomp would cause patient safety concerns and delay care.

• Not specified, but the decision supports a brand name decision for Micromedex.

• Not applicable, as this is a sole source award decision document.

• Acquisition Plan Action ID: 36C259-26-AP-2357

• JOFOC Tracking Number: FY26 – NCO 19 - 877

• The decision is deemed in the best interest of the Government.

Statement of Need

To retain current access to the Micromedex and Poison Index information platform for the Cheyenne VA Medical Clinic to support effective clinical decision-making.

This procurement covers access to the full suite of Micromedex resources, including:

• Drug information

• Disease and condition management content

• Toxicology data

• Drug interaction checker

• IV compatibility information

• Care Notes

• RED BOOK pricing and product information

• Comprehensive, evidence-based clinical information for healthcare professionals.

• Improved quality of patient care through enhanced clinical decision support.

• Access to the latest drug information (dosing, contraindications, adverse effects).

• Quick and accurate drug interaction checks and toxicology management.

• User licenses for healthcare professionals.

• Training and support materials.

• Regular updates to ensure information remains current and evidence-based.

• Access to customer support.

Cheyenne VA Medical Center 2365 EAST PERSHING BLVD CHEYENNE, WY 82001

Solicitation / RFP / RFQ

This is a combined synopsis/solicitation (Request for Quote - RFQ) for Micromedex subscription services for the Cheyenne VA Medical Center. The government is seeking to award a firm-fixed-price contract for a base year plus four option years.

• Annual Subscription for Micromedex Expanded Drug with POISINDEX.

• The requirement is for Micromedex services, with specific details to be referenced in the attached "Statement of Need."

• Contract Type: Firm-fixed price.

• Period of Performance:

  • Base Year: 04/16/2026 - 04/15/2027
  • Option Year 1: 04/16/2027 - 04/16/2028
  • Option Year 2: 04/16/2028 - 04/15/2029
  • Option Year 3: 04/16/2029 - 04/15/2030
  • Option Year 4: 04/16/2030 - 04/15/2031

• Delivery and Acceptance: F.O.B Destination at Cheyenne VA Medical Center, Cheyenne, WY.

• Submission Deadline: April 7, 2026, 14:00 Mountain Time.

• Submission Method: Email quotes only to Danielle.kramer@va.gov (4MB email limit). Faxed or hand-carried quotes will not be accepted.

• Evaluation Factors: Quotes will be evaluated based on:

  • Factor I: Technical capability or quality.
  • Factor II: Price.
  • Factor III: Past Performance.

• Award Basis: The government reserves the right to make an award solely on initial quotes received and will award to the responsible offeror whose quote is most advantageous to the government, considering price and other factors.

• All or Nothing Basis: Any award made will be on an all-or-nothing basis.

• Set-Aside: Total Small Business (SB) set-aside.

• NAICS Code: 519290 (Web Search Portals and All Other Information Services) with a size standard of 1,000 Employees.

• SB Verification: Socioeconomic status must be verified and visible in the SBA Small Business Certification (SBS) at the time of quote submission and award.

• All questions must be submitted in writing and will be answered via solicitation amendment.

• Offerors must complete the RFQ in its entirety, including signing and dating.

• Submission volumes required: Technical capability, Price, and Past Performance.

• Refer to attached "Statement of Need" and "Brand Name Decision" documents.